Stocks  /  NASDAQ  /  Avalyn Pharma Inc.

Avalyn Pharma Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   AVLN – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Avalyn Pharma Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Company Description

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.

Company Website: https://www.avalynpharma.com

Contact:  ir@avalynpharma.com
Scroll to Top